De Sarro G - Search Results

1

Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy.

Russo E, Constanti A, Ferreri G, Citraro R, De Sarro G. Russo E, et al. Among authors: de sarro g. Neuropharmacology. 2004 May;46(6):865-78. doi: 10.1016/j.neuropharm.2003.11.028. Neuropharmacology. 2004. PMID: 15033346

2

Anticonvulsant activity of competitive antagonists of NMDA receptor in genetically epilepsy-prone rats.

De Sarro G, De Sarro A. De Sarro G, et al. Among authors: de sarro a. Eur J Pharmacol. 1992 May 14;215(2-3):221-9. doi: 10.1016/0014-2999(92)90031-x. Eur J Pharmacol. 1992. PMID: 1396987

3

Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.

De Sarro G, Ongini E, Bertorelli R, Aguglia U, De Sarro A. De Sarro G, et al. Among authors: de sarro a. Eur J Pharmacol. 1994 Sep 1;262(1-2):11-9. doi: 10.1016/0014-2999(94)90022-1. Eur J Pharmacol. 1994. PMID: 7529182

4

Effects of interleukin-2 on various models of experimental epilepsy in DBA/2 mice.

De Sarro G, Rotiroti D, Audino MG, Gratteri S, Nisticó G. De Sarro G, et al. Neuroimmunomodulation. 1994 Nov-Dec;1(6):361-9. doi: 10.1159/000097189. Neuroimmunomodulation. 1994. PMID: 7671124 Free article.

5

Fenbufen pretreatment potentiates the anticonvulsant activity of CPPene and NBQX in DBA/2 mice.

De Sarro G, Renne S, Nava F, De Sarro A. De Sarro G, et al. Among authors: de sarro a. J Pharm Pharmacol. 1994 Dec;46(12):1017-22. doi: 10.1111/j.2042-7158.1994.tb03259.x. J Pharm Pharmacol. 1994. PMID: 7714713

6

Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice.

De Sarro G, Nava F, Aguglia U, De Sarro A. De Sarro G, et al. Among authors: de sarro a. Neuropharmacology. 1996 Feb;35(2):153-8. doi: 10.1016/0028-3908(95)00174-3. Neuropharmacology. 1996. PMID: 8734483

7

Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats.

De Sarro G, Di Paola ED, Aguglia U, de Sarro A. De Sarro G, et al. Among authors: de sarro a. Pharmacol Biochem Behav. 1996 Sep;55(1):39-48. doi: 10.1016/0091-3057(96)00062-7. Pharmacol Biochem Behav. 1996. PMID: 8870036

8

Lack of development of tolerance to anticonvulsant effects of two excitatory amino acid antagonists, CGP [corrected] 37849 and CGP 39551 in genetically epilepsy-prone rats.

De Sarro G, De Sarro A, Ammendola D, Patel S. De Sarro G, et al. Among authors: de sarro a. Brain Res. 1996 Sep 23;734(1-2):91-7. Brain Res. 1996. PMID: 8896813

9

Repeated treatment with adenosine A1 receptor agonist and antagonist modifies the anticonvulsant properties of CPPene.

De Sarro G, Donato Di Paola E, Falconi U, Ferreri G, De Sarro A. De Sarro G, et al. Among authors: de sarro a. Eur J Pharmacol. 1996 Dec 19;317(2-3):239-45. doi: 10.1016/s0014-2999(96)00746-7. Eur J Pharmacol. 1996. PMID: 8997606

10

1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.

Chimirri A, De Sarro G, De Sarro A, Gitto R, Grasso S, Quartarone S, Zappalà M, Giusti P, Libri V, Constanti A, Chapman AG. Chimirri A, et al. Among authors: de sarro a, de sarro g. J Med Chem. 1997 Apr 11;40(8):1258-69. doi: 10.1021/jm960506l. J Med Chem. 1997. PMID: 9111300

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters